The role of IDO in brain tumor immunotherapy.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 395, doi. 10.1007/s11060-014-1687-8
- By:
- Publication type:
- Article
Works matching IS 0167594X AND DT 2015 AND VI 123 AND IP 3
Results: 18
1
2
Current challenges in designing GBM trials for immunotherapy.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 331, doi. 10.1007/s11060-015-1716-2
- By:
- Publication type:
- Article
3
Glioblastoma stem cells and stem cell-targeting immunotherapies.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 449, doi. 10.1007/s11060-015-1729-x
- By:
- Publication type:
- Article
4
Genetics and immunotherapy: using the genetic landscape of gliomas to inform management strategies.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 373, doi. 10.1007/s11060-015-1730-4
- By:
- Publication type:
- Article
5
The role of STAT3 in tumor-mediated immune suppression.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 385, doi. 10.1007/s11060-015-1731-3
- By:
- Publication type:
- Article
6
Cytomegalovirus and glioblastoma; controversies and opportunities.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 465, doi. 10.1007/s11060-015-1734-0
- By:
- Publication type:
- Article
7
Biomarkers for glioma immunotherapy: the next generation.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 359, doi. 10.1007/s11060-015-1746-9
- By:
- Publication type:
- Article
8
The role of checkpoints in the treatment of GBM.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 413, doi. 10.1007/s11060-015-1747-8
- By:
- Publication type:
- Article
9
Re-defining response and treatment effects for neuro-oncology immunotherapy clinical trials.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 339, doi. 10.1007/s11060-015-1748-7
- By:
- Publication type:
- Article
10
Combining immunotherapy with radiation for the treatment of glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 459, doi. 10.1007/s11060-015-1762-9
- By:
- Publication type:
- Article
11
Concepts of immunotherapy for glioma.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 323, doi. 10.1007/s11060-015-1810-5
- By:
- Publication type:
- Article
12
Nanotechnology to augment immunotherapy for the treatment of glioblastoma multiforme.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 473, doi. 10.1007/s11060-015-1814-1
- By:
- Publication type:
- Article
13
Dendritic cell immunotherapy for brain tumors.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 425, doi. 10.1007/s11060-015-1830-1
- By:
- Publication type:
- Article
14
Glioblastoma antigen discovery-foundations for immunotherapy.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 347, doi. 10.1007/s11060-015-1836-8
- By:
- Publication type:
- Article
15
Heat shock protein vaccines against glioblastoma: from bench to bedside.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 441, doi. 10.1007/s11060-015-1837-7
- By:
- Publication type:
- Article
16
Introduction: brain tumor immunotherapy.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
17
The role of regulatory T cells and microglia in glioblastoma-associated immunosuppression.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 405, doi. 10.1007/s11060-015-1849-3
- By:
- Publication type:
- Article
18
Peptide vaccines for the treatment of glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 433, doi. 10.1007/s11060-014-1676-y
- By:
- Publication type:
- Article